Oxford Medical Products has revealed positive topline results from the first randomised controlled trial (RCT) of Sirona, its innovative, non-invasive and non-pharmaceutical weight loss technology.
The NHS has drawn up a list of surgeries that could potentially get its funding axed in order to save £2 billion of taxpayer money
More from us
Did you know with an ad-lite subscription to Melton Times, you get 70% fewer ads while viewing the news that matters to you.
.jpg?trim=0,504,0,504&crop=&quality=70&width=129)
.jpg?trim=469,0,469,0&crop=&quality=70&width=129)
.jpeg?trim=261,0,750,0&crop=&quality=70&width=280)
